Name
Lümfoloogia- ja Taastusravikeskus OÜ
Registry code
12623143
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.03.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86909 - Other healthcare activities not classified elsewhere
60 677 €
4 868 €
8%
1 141 €
(estimate is approximate)
13 472 €
2
Submitted
No tax arrears
36%
25%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Annika Albert-Aksjonov 23.03.1977 (47) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| Kalju Albert 08.12.1954 (69) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| 2019 16.07.2020 | 2020 05.08.2021 | 2021 21.07.2022 | 2022 13.07.2023 | 2023 21.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 39 354 € | 23 530 € | 41 399 € | 48 425 € | 60 677 € |
| Net profit (loss) for the period | 3 235 € | -3 049 € | 327 € | 196 € | 4 868 € |
| Profit Margin | 8% | -13% | 1% | 0% | 8% |
| Current Assets | 10 189 € | 7 151 € | 8 738 € | 8 445 € | 16 605 € |
| Fixed Assets | 3 673 € | 4 296 € | 3 747 € | 3 118 € | 2 538 € |
| Total Assets | 13 862 € | 11 447 € | 12 485 € | 11 563 € | 19 143 € |
| Current Liabilities | 2 732 € | 3 366 € | 4 077 € | 2 959 € | 5 671 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 11 130 € | 8 081 € | 8 408 € | 8 604 € | 13 472 € |
| Employees | 1 | 1 | 1 | 1 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 2 702.23 € | 2 921.58 € | 3 |
| 2023 Q4 | - | 2 250.75 € | 2 433.92 € | 3 |
| 2023 Q3 | - | 2 985.51 € | 3 226.81 € | 3 |
| 2023 Q2 | - | 2 491.47 € | 2 700.75 € | 3 |
| 2023 Q1 | - | 2 315.7 € | 2 504.15 € | 3 |
| 2022 Q4 | - | 2 644.38 € | 2 833.3 € | 3 |
| 2022 Q3 | - | 2 491.7 € | 2 658.19 € | 3 |
| 2022 Q2 | - | 2 147.25 € | 2 289.76 € | 3 |
| 2022 Q1 | - | 2 447.79 € | 2 612.9 € | 3 |
| 2021 Q4 | - | 1 974.05 € | 2 092.23 € | 3 |
| 2021 Q3 | - | 1 645.81 € | 1 809.57 € | 3 |
| 2021 Q2 | - | 2 733.14 € | 3 010.97 € | 3 |
| 2021 Q1 | - | 2 208.95 € | 2 445.36 € | 3 |
| 2020 Q4 | - | 1 598.25 € | 1 756.7 € | 3 |
| 2020 Q3 | - | 1 438.34 € | 1 594.48 € | 2 |
| 2020 Q2 | - | 828.52 € | 916.98 € | 2 |
| 2020 Q1 | - | 1 723.7 € | 1 899.57 € | 2 |
